Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 12, 2026 · Item 5.07
Janux Therapeutics, Inc.
4
Item 5.07
Jun 12, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Item 5.07 |
| Primary topic | Item 5.07 |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Janux Therapeutics, Inc. filed this 8-K to disclose: ) 10955 Vista Sorrento Parkway , Suite 200 San Diego , California 92130 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: (858) 751-4493 N/A (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 11, 2026 |
| Accession number | 0001193125-26-269387 |
| Reported items | Item 5.07 See Analysis tab for workforce implications |
